Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
Alteplase DosingAmphotericin B DosingArgatroban InfusionBivalirudin InfusionCisatracurium Infusion RateClevidipine Infusion RateColistin Loading and MaintenanceDaptomycin DoseDexmedetomidine Infusion RateDobutamine Infusion RateDopamine Infusion RateEnteral Nutrition RateEpinephrine Infusion RateEsmolol Infusion RateFentanyl Infusion RateFluid ResuscitationFondaparinux Therapeutic DosingHeparin NomogramHydromorphone Infusion RateHypertonic Saline Infusion RateIV Calcium Gluconate DoseIV Hydralazine DoseIV Labetalol DoseIV Magnesium ReplacementIV Nicardipine Infusion RateIV Nitroglycerin Infusion RateIV Phosphate ReplacementIV Potassium ReplacementKetamine Infusion RateMeropenem Extended InfusionMidazolam Infusion RateMilrinone Infusion RateMorphine Infusion RateNorepinephrine Infusion RateParkland FormulaPhenylephrine Infusion RatePiperacillin-Tazobactam Extended InfusionPropofol Infusion RateProtamine Reversal DoseRocuronium DoseSodium Correction RateSodium Nitroprusside InfusionSuccinylcholine DoseTPN Calorie and ProteinTenecteplase DosingVancomycin Continuous InfusionVasopressin Infusion RateVecuronium DoseVitamin K Reversal DoseWater Deficit Hypernatremia
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

Tropical Med & Intl HealthJun 20, 2026
Uncomplicated Malaria in Infancy and Neurodevelopment at 1 and 6 Years: Evidence From the MiPPAD Birth Cohort Study of Benin

Clinical Context

We think this has broad domain relevance to IV Potassium Replacement.

FDA MedWatchJun 17, 2026
UPDATE: Hintermann Series H3 Total Ankle Replacement Has a Higher-Than-Expected Risk of Device Failure: FDA Safety Communication

Clinical Context

We think this might be relevant to the clinical guidance for IV Potassium Replacement.

FDA MedWatchJun 12, 2026
Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement - FDA Safety Communication

Clinical Context

We think this might be relevant to the clinical guidance for IV Potassium Replacement.

IV Potassium Replacement

ELECTROLYTEPotassium Chloride (KCl)

Lab & Access

mEq/L

Potassium Dose

Calculate appropriate IV Potassium doses and safe infusion rates based on serum levels and IV access.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Overview

Clinical content for IV Potassium Replacement is currently under development.

Last Comprehensive Review: 2026